 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Aclaris Therapeutics Inc. (ACRS)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-06-27 Sale | 2019-07-01 5:01 pm | Aclaris Therapeutics Inc. | ACRS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 699,475 | $2.691 | $1,882,077 | 3,159,165 (Indirect) | View |
| 2019-06-26 Sale | 2019-06-26 5:52 pm | Aclaris Therapeutics Inc. | ACRS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 1,704 | $4.502 | $7,671 | 3,749,966 (Indirect) | View |
| 2019-06-21 Sale | 2019-06-25 6:31 pm | Aclaris Therapeutics Inc. | ACRS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 454,261 | $4.59 | $2,085,238 | 3,842,345 (Indirect) | View |
| 2019-05-09 Sale | 2019-05-13 5:24 pm | Aclaris Therapeutics Inc. | ACRS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 614,710 | $6.126 | $3,765,522 | 4,220,443 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-10-30 Option Award | 2019-10-31 4:18 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2019-07-02 Option Award | 2019-07-03 4:47 pm | N/A 2029-07-01 | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 16,000 | $2.34 | 16,000 (Direct) | View |
| 2019-07-02 Exercise | 2019-07-03 4:44 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 6,000 | $0 | 18,000 (Direct) | View |
| 2019-07-02 Tax Withholding | 2019-07-03 4:44 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 1,648 | $2.34 | 18,000 (Direct) | View |
| 2019-07-02 Exercise | 2019-07-03 4:44 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 6,000 | $0 | 18,000 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 5:47 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 7,333 | $0 | 7,333 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 4:56 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director | 7,333 | $0 | 7,333 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 4:52 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 7,333 | $0 | 7,333 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 4:51 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director | 7,333 | $0 | 7,333 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 4:50 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director | 7,333 | $0 | 7,333 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 4:49 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 7,333 | $0 | 7,333 (Direct) | View |
| 2019-03-01 Option Award | 2019-03-04 6:13 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 68,700 | $0 | 68,700 (Direct) | View |
| 2019-03-01 Option Award | 2019-03-04 6:12 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 384,600 | $0 | 384,600 (Direct) | View |
| 2019-03-01 Option Award | 2019-03-04 6:11 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 103,000 | $0 | 103,000 (Direct) | View |
| 2019-03-01 Option Award | 2019-03-04 6:10 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer | 82,400 | $0 | 82,400 (Direct) | View |
| 2019-03-01 Option Award | 2019-03-04 6:09 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Shanler Stuart Chief Scientific Officer | 82,200 | $0 | 82,200 (Direct) | View |
| 2019-02-01 Exercise | 2019-02-05 6:34 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 10,800 | $0 | 920,924 (Direct) | View |
| 2019-02-01 Tax Withholding | 2019-02-05 6:34 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 3,579 | $6.96 | 920,924 (Direct) | View |
| 2019-02-01 Exercise | 2019-02-05 6:34 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 10,800 | $0 | 920,924 (Direct) | View |
| 2019-02-01 Exercise | 2019-02-05 6:33 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powala Christopher Chief Reg & Develop Officer | 3,400 | $0 | 142,843 (Direct) | View |
| 2019-02-01 Tax Withholding | 2019-02-05 6:33 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powala Christopher Chief Reg & Develop Officer | 1,114 | $6.96 | 142,843 (Direct) | View |
| 2019-02-01 Exercise | 2019-02-05 6:33 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powala Christopher Chief Reg & Develop Officer | 3,400 | $0 | 142,843 (Direct) | View |
| 2019-02-01 Exercise | 2019-02-05 6:32 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Shanler Stuart Chief Scientific Officer | 3,875 | $0 | 273,355 (Direct) | View |
| 2019-02-01 Tax Withholding | 2019-02-05 6:32 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Shanler Stuart Chief Scientific Officer | 1,308 | $6.96 | 273,355 (Direct) | View |
| 2019-02-01 Exercise | 2019-02-05 6:32 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Shanler Stuart Chief Scientific Officer | 3,875 | $0 | 273,355 (Direct) | View |
| 2019-02-01 Exercise | 2019-02-05 6:31 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 3,875 | $0 | 166,284 (Direct) | View |
| 2019-02-01 Tax Withholding | 2019-02-05 6:31 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 1,308 | $6.96 | 166,284 (Direct) | View |
| 2019-02-01 Exercise | 2019-02-05 6:31 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 3,875 | $0 | 166,284 (Direct) | View |
| 2019-02-01 Exercise | 2019-02-05 6:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Fair Brett Chief Commercial Officer | 3,875 | $0 | 11,890 (Direct) | View |
| 2019-02-01 Tax Withholding | 2019-02-05 6:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Fair Brett Chief Commercial Officer | 1,308 | $6.96 | 11,890 (Direct) | View |
| 2019-02-01 Exercise | 2019-02-05 6:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Fair Brett Chief Commercial Officer | 3,875 | $0 | 11,890 (Direct) | View |
| 2019-02-01 Exercise | 2019-02-05 6:29 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 3,875 | $0 | 83,520 (Direct) | View |
| 2019-02-01 Tax Withholding | 2019-02-05 6:29 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 1,308 | $6.96 | 83,520 (Direct) | View |
| 2019-02-01 Exercise | 2019-02-05 6:29 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 3,875 | $0 | 83,520 (Direct) | View |
| 2019-01-11 Other | 2019-01-18 2:55 pm | N/A 2022-01-19 | Aclaris Therapeutics Inc. | ACRS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 1 | $7 | 4,481,788 (Indirect) | View |
| 2019-01-11 Other | 2019-01-18 2:55 pm | N/A 2022-01-19 | Aclaris Therapeutics Inc. | ACRS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 1 | $6.969 | 4,481,788 (Indirect) | View |
| 2019-01-11 Other | 2019-01-18 2:55 pm | N/A 2022-01-19 | Aclaris Therapeutics Inc. | ACRS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 1 | $6.931 | 4,481,788 (Indirect) | View |
| 2018-12-28 Other | 2019-01-02 5:33 pm | N/A 2022-01-19 | Aclaris Therapeutics Inc. | ACRS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 1 | $6.999 | 4,481,788 (Indirect) | View |
| 2018-12-24 Other | 2018-12-27 7:07 pm | N/A 2022-01-19 | Aclaris Therapeutics Inc. | ACRS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 1 | $6.919 | 4,481,788 (Indirect) | View |
| 2018-12-24 Other | 2018-12-27 7:07 pm | N/A 2022-01-19 | Aclaris Therapeutics Inc. | ACRS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 1 | $6.855 | 4,481,788 (Indirect) | View |
| 2018-12-24 Other | 2018-12-27 7:07 pm | N/A 2022-01-19 | Aclaris Therapeutics Inc. | ACRS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 1 | $6.889 | 4,481,788 (Indirect) | View |
| 2018-12-19 Other | 2018-12-21 7:16 pm | N/A 2022-01-19 | Aclaris Therapeutics Inc. | ACRS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 1 | $6.914 | 4,481,788 (Indirect) | View |
| 2018-12-19 Other | 2018-12-21 7:16 pm | N/A 2022-01-19 | Aclaris Therapeutics Inc. | ACRS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 1 | $6.842 | 4,481,788 (Indirect) | View |
| 2018-12-19 Other | 2018-12-21 7:16 pm | N/A 2022-01-19 | Aclaris Therapeutics Inc. | ACRS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 1 | $6.945 | 4,481,788 (Indirect) | View |
| 2018-12-18 Exercise | 2018-12-21 07:34 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 1,250 | $0 | 162,765 (Direct) | View |
| 2018-12-18 Tax Withholding | 2018-12-21 07:34 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 356 | $6.3 | 162,765 (Direct) | View |
| 2018-12-18 Exercise | 2018-12-21 07:34 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 1,250 | $0 | 162,765 (Direct) | View |
| 2018-12-18 Exercise | 2018-12-21 07:33 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 2,925 | $0 | 910,957 (Direct) | View |
| 2018-12-18 Tax Withholding | 2018-12-21 07:33 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 833 | $6.3 | 910,957 (Direct) | View |
| 2018-12-18 Exercise | 2018-12-21 07:33 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 2,925 | $0 | 910,957 (Direct) | View |
| 2018-12-18 Exercise | 2018-12-21 07:32 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Shanler Stuart Chief Scientific Officer | 1,450 | $0 | 269,892 (Direct) | View |
| 2018-12-18 Tax Withholding | 2018-12-21 07:32 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Shanler Stuart Chief Scientific Officer | 412 | $6.3 | 269,892 (Direct) | View |
| 2018-12-18 Exercise | 2018-12-21 07:32 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Shanler Stuart Chief Scientific Officer | 1,450 | $0 | 269,892 (Direct) | View |
| 2018-12-18 Exercise | 2018-12-21 07:31 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Fair Brett Chief Commercial Officer | 1,750 | $0 | 8,513 (Direct) | View |
| 2018-12-18 Tax Withholding | 2018-12-21 07:31 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Fair Brett Chief Commercial Officer | 498 | $6.3 | 8,513 (Direct) | View |
| 2018-12-18 Exercise | 2018-12-21 07:31 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Fair Brett Chief Commercial Officer | 1,750 | $0 | 8,513 (Direct) | View |
| 2018-12-18 Exercise | 2018-12-21 07:29 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powala Christopher Chief Reg & Develop Officer | 1,625 | $0 | 139,889 (Direct) | View |
| 2018-12-18 Tax Withholding | 2018-12-21 07:29 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powala Christopher Chief Reg & Develop Officer | 446 | $6.3 | 139,889 (Direct) | View |
| 2018-12-18 Exercise | 2018-12-21 07:29 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powala Christopher Chief Reg & Develop Officer | 1,625 | $0 | 139,889 (Direct) | View |
| 2018-12-18 Exercise | 2018-12-20 9:59 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 1,075 | $0 | 79,951 (Direct) | View |
| 2018-12-18 Tax Withholding | 2018-12-20 9:59 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 306 | $6.3 | 79,951 (Direct) | View |
| 2018-12-18 Exercise | 2018-12-20 9:59 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 1,075 | $0 | 79,951 (Direct) | View |
| 2018-12-15 Exercise | 2018-12-18 8:54 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 3,033 | $0 | 908,895 (Direct) | View |
| 2018-12-15 Tax Withholding | 2018-12-18 8:54 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 863 | $7.31 | 908,895 (Direct) | View |
| 2018-12-15 Exercise | 2018-12-18 8:54 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO | 3,033 | $0 | 908,895 (Direct) | View |
| 2018-12-15 Exercise | 2018-12-18 8:54 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 1,300 | $0 | 161,885 (Direct) | View |
| 2018-12-15 Tax Withholding | 2018-12-18 8:54 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 370 | $7.31 | 161,885 (Direct) | View |
| 2018-12-15 Exercise | 2018-12-18 8:54 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank CFO | 1,300 | $0 | 161,885 (Direct) | View |
| 2018-12-15 Exercise | 2018-12-18 8:53 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Shanler Stuart Chief Scientific Officer | 1,300 | $0 | 268,812 (Direct) | View |
| 2018-12-15 Tax Withholding | 2018-12-18 8:53 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Shanler Stuart Chief Scientific Officer | 370 | $7.31 | 268,812 (Direct) | View |
| 2018-12-15 Exercise | 2018-12-18 8:53 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Shanler Stuart Chief Scientific Officer | 1,300 | $0 | 268,812 (Direct) | View |
| 2018-12-15 Exercise | 2018-12-18 8:52 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 1,733 | $0 | 79,369 (Direct) | View |
| 2018-12-15 Tax Withholding | 2018-12-18 8:52 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 493 | $7.31 | 79,369 (Direct) | View |
| 2018-12-15 Exercise | 2018-12-18 8:52 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer | 1,733 | $0 | 79,369 (Direct) | View |
| 2018-12-15 Exercise | 2018-12-18 8:51 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powala Christopher Chief Reg & Develop Officer | 1,300 | $0 | 138,621 (Direct) | View |
| 2018-12-15 Tax Withholding | 2018-12-18 8:51 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powala Christopher Chief Reg & Develop Officer | 357 | $7.31 | 138,621 (Direct) | View |
| 2018-12-15 Exercise | 2018-12-18 8:51 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powala Christopher Chief Reg & Develop Officer | 1,300 | $0 | 138,621 (Direct) | View |
| 2018-12-15 Exercise | 2018-12-18 8:51 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Fair Brett Chief Commercial Officer | 1,013 | $0 | 7,051 (Direct) | View |
| 2018-12-15 Tax Withholding | 2018-12-18 8:51 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Fair Brett Chief Commercial Officer | 288 | $7.31 | 7,051 (Direct) | View |
| 2018-12-15 Exercise | 2018-12-18 8:51 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Fair Brett Chief Commercial Officer | 1,013 | $0 | 7,051 (Direct) | View |